These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30586926)

  • 41. Report of two Syrian siblings with Mulibrey nanism.
    Al Saadi T; Alkhatib M; Turk T; Turkmani K; Abbas F; Khouri L
    Oxf Med Case Reports; 2015 Dec; 2015(12):367-70. PubMed ID: 26664725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism.
    Avela K; Lipsanen-Nyman M; Idänheimo N; Seemanová E; Rosengren S; Mäkelä TP; Perheentupa J; Chapelle AD; Lehesjoki AE
    Nat Genet; 2000 Jul; 25(3):298-301. PubMed ID: 10888877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
    Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
    Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A stone was lifted from her heart: pericardial constriction in 28-year-old patient with Mulibrey nanism.
    Baczewski K; Czajkowski M; Olszewski K; Stadnik A; Stążka J
    Kardiol Pol; 2016; 74(2):192. PubMed ID: 27150563
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ascites in Mulibrey syndrome].
    Husová L; Husa P
    Vnitr Lek; 2009 Jun; 55(6):604-7. PubMed ID: 19662894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mulibrey nanism: clinical features and diagnostic criteria.
    Karlberg N; Jalanko H; Perheentupa J; Lipsanen-Nyman M
    J Med Genet; 2004 Feb; 41(2):92-8. PubMed ID: 14757854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mulibrey Nanism and the Real Time Use of Genome and Biobank Engines to Inform Clinical Care in an Ultrarare Disease.
    Weldy CS; Ashley EA
    Circ Genom Precis Med; 2021 Jun; 14(3):e003430. PubMed ID: 34096331
    [No Abstract]   [Full Text] [Related]  

  • 48. Mulibrey nanism.
    Balg S; Stengel-Rutkowski S; Döhlemann C; Boergen K
    Clin Dysmorphol; 1995 Jan; 4(1):63-9. PubMed ID: 7735507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TRIM37 promotes epithelial‑mesenchymal transition in colorectal cancer.
    Hu CE; Gan J
    Mol Med Rep; 2017 Mar; 15(3):1057-1062. PubMed ID: 28098873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of MUL, a gene encoding a novel RBCC family ring-finger protein, in human and mouse embryogenesis.
    Lehesjoki AE; Reed VA; Mark Gardiner R; Greene ND
    Mech Dev; 2001 Oct; 108(1-2):221-5. PubMed ID: 11578880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
    Tang SL; Gao YL; Wen-Zhong H
    Biomed Pharmacother; 2018 Mar; 99():59-64. PubMed ID: 29324313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth and growth hormone therapy in subjects with mulibrey nanism.
    Karlberg N; Jalanko H; Lipsanen-Nyman M
    Pediatrics; 2007 Jul; 120(1):e102-11. PubMed ID: 17548484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRIM37 promoted the growth and migration of the pancreatic cancer cells.
    Jiang J; Tian S; Yu C; Chen M; Sun C
    Tumour Biol; 2016 Feb; 37(2):2629-34. PubMed ID: 26395261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mass ascites in Mulibrey nanism.
    Husova L; Husa P; Brychta T
    J Pediatr Endocrinol Metab; 2010 Sep; 23(9):863-5. PubMed ID: 21175083
    [No Abstract]   [Full Text] [Related]  

  • 55. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis.
    Xie H; Xie D; Zhang J; Jin W; Li Y; Yao J; Pan Z; Xie D
    Mol Ther Nucleic Acids; 2020 Aug; 22():114-123. PubMed ID: 32916597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRIM37 exacerbates hepatic ischemia/reperfusion injury by facilitating IKKγ translocation.
    Yang H; Huang Z; Luo Y; Lei D; Yan P; Shen A; Liu W; Li D; Wu Z
    Mol Med; 2023 May; 29(1):62. PubMed ID: 37158850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
    Jiang J; Yu C; Chen M; Tian S; Sun C
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1120-1127. PubMed ID: 26208456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mulibrey nanism: review of 23 cases of a new autosomal recessive syndrome.
    Perheentupa J; Autio S; Leisti S; Raitta C; Tuuteri L
    Birth Defects Orig Artic Ser; 1975; 11(2):3-17. PubMed ID: 1227534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mulibrey nanism: three additional patients and a review of 39 patients.
    Lapunzina P; Rodríguez JI; de Matteo E; Gracia R; Moreno F
    Am J Med Genet; 1995 Jan; 55(3):349-55. PubMed ID: 7726235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth failure with pericardial constriction. The syndrome of mulibrey nanism.
    Voorhess ML; Husson GS; Blackman MS
    Am J Dis Child; 1976 Oct; 130(10):1146-8. PubMed ID: 135512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.